This page is not available in the language that has been selected and will appear in English.
This page is not available in the language that has been selected.
Halaman ini tidak tersedia dalam bahasa yang dipilih.
Trang này không có sẵn bằng ngôn ngữ đã chọn.
此页面不提供所选语言的版本。
07 3737 4500
This guide helps you understand your diagnosis, explore care options, and support yourself and others during treatment.
We cover essential terminology including treatment terms, medical procedures, common side effects, and more.
Your options for treatment may be varied or few, so our guide has endeavoured to offer an extensive run-down of options.
Find a clinical trial that may suit you and your cancer diagnosis
WOMBAT / ANZUP 2201
Evaluating the efficacy of bipolar androgen therapy in extending metastasis-free survival in patients with M0 castrate-resistant prostate cancer with prostate specific antigen progression but not radiological or clinical progression on darolutamide
Locations Chermside
Diagnosis Prostate cancer
MEVPRO-1 / C2321014
A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer
Locations Wesley
NIAGARA-2 / D933RC00002
Perioperative Durvalumab With Neoadjuvant ddMVAC or Gemcitabine/Cisplatin in Patients With Muscle-invasive Bladder Cancer
Diagnosis Bladder cancer
SKB264-II-06
SKB264 in Combination With Pembrolizumab in Subjects With Selected Solid Tumors
Diagnosis Advanced solid tumours
RAMP 301 / VS-6766-301
A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serious Ovarian Cancer
Diagnosis Ovarian cancer
ZN-c3-005
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer (DENALI)
Previous